Oral vaccine shows promise; hypertension ups COVID hospitalization risk

Oral vaccine shows promise; hypertension ups COVID hospitalization risk The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Nancy Lapid Reuters

...

An experimental COVID-19 vaccine in the form of an oral tablet has shown promising immune responses in a small preliminary trial designed mainly to evaluate its safety, according to drug manufacturer Vaxart Inc (VXRT.O). The South San Francisco, California-based company had earlier said the tablet was well tolerated, with no one dropping out of the study because of adverse effects. On Tuesday, they reported on immune responses in the 35 healthy volunteers who received the tablet...